SELLAS Life Sciences Group Announces Warrant Inducement Agreement

On October 24, 2025, SELLAS Life Sciences Group, Inc. entered into a Warrant Inducement Agreement with holders of existing warrants to purchase shares of the company's common stock. The agreement allows for the cash exercise of warrants to purchase up to 6,514,658 shares at $1.535 per share and up to 15,849,056 shares at $1.325 per share. In return, the company will issue new warrants to purchase up to 22,363,714 shares of common stock at $2.00 per share, exercisable immediately and expiring five years from the issuance date. The company expects to receive approximately $31.0 million in gross proceeds from the exercise of the existing warrants. The agreement also includes restrictions on the company's ability to issue new shares or file registration statements for 75 days and prohibits variable rate transactions for 12 months.